Analystreport

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is now covered by analysts at Cowen Inc. They set a "buy" rating and a $32.00 price target on the stock.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report